CYBB and chronic granulomatous disease: Actually, the Nox2 anti-inflammatory effects were extensively demonstrated in murine models2, 3, 4, 5 and in CGD patients1, 6, however the precise intracellular mechanisms mediated by Nox2 have not being elucidated previously.